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Intact microtubules support adenovirus and herpes simplex virus
infections
Abstract
Capsids and the enclosed DNA of adenoviruses, including the species C viruses adenovirus type 2 (Ad2)
and Ad5, and herpesviruses, such as herpes simplex virus type 1 (HSV-1), are targeted to the nuclei of
epithelial, endothelial, fibroblastic, and neuronal cells. Cytoplasmic transport of fluorophore-tagged Ad2
and immunologically detected HSV-1 capsids required intact microtubules and the
microtubule-dependent minus-end-directed motor complex dynein-dynactin. A recent study with
epithelial cells suggested that Ad5 was transported to the nucleus and expressed its genes independently
of a microtubule network. To clarify the mechanisms by which Ad2 and, as an independent control,
HSV-1 were targeted to the nucleus, we treated epithelial cells with nocodazole (NOC) to depolymerize
microtubules and measured viral gene expression at different times and multiplicities of infections. Our
results indicate that in NOC-treated cells, viral transgene expression was significantly reduced at up to
48 h postinfection (p.i.). A quantitative analysis of subcellular capsid localization indicated that NOC
blocked the nuclear targeting of Ad2 and also HSV-1 by more than 90% at up to 7 h p.i. About 10% of
the incoming Texas Red-coupled Ad2 (Ad2-TR) was enriched at the nucleus in microtubule-depleted
cells at 5 h p.i. This result is consistent with earlier observations that Ad2-TR capsids move randomly in
NOC-treated cells at less than 0.1 micro m/s and over distances of less than 5 micro m, characteristic of
Brownian motion. We conclude that fluorophore-tagged Ad2 and HSV-1 particles are infectious and
that microtubules play a prominent role in efficient nuclear targeting during entry and gene expression
of species C Ads and HSV-1.
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Capsids and the enclosed DNA of adenoviruses, including the species C viruses adenovirus type 2 (Ad2) and
Ad5, and herpesviruses, such as herpes simplex virus type 1 (HSV-1), are targeted to the nuclei of epithelial,
endothelial, fibroblastic, and neuronal cells. Cytoplasmic transport of fluorophore-tagged Ad2 and immuno-
logically detected HSV-1 capsids required intact microtubules and the microtubule-dependent minus-end-
directed motor complex dynein-dynactin. A recent study with epithelial cells suggested that Ad5 was trans-
ported to the nucleus and expressed its genes independently of a microtubule network. To clarify the
mechanisms by which Ad2 and, as an independent control, HSV-1 were targeted to the nucleus, we treated
epithelial cells with nocodazole (NOC) to depolymerize microtubules and measured viral gene expression at
different times and multiplicities of infections. Our results indicate that in NOC-treated cells, viral transgene
expression was significantly reduced at up to 48 h postinfection (p.i.). A quantitative analysis of subcellular
capsid localization indicated that NOC blocked the nuclear targeting of Ad2 and also HSV-1 by more than 90%
at up to 7 h p.i. About 10% of the incoming Texas Red-coupled Ad2 (Ad2-TR) was enriched at the nucleus in
microtubule-depleted cells at 5 h p.i. This result is consistent with earlier observations that Ad2-TR capsids
move randomly in NOC-treated cells at less than 0.1 m/s and over distances of less than 5 m, characteristic
of Brownian motion. We conclude that fluorophore-tagged Ad2 and HSV-1 particles are infectious and that
microtubules play a prominent role in efficient nuclear targeting during entry and gene expression of species
C Ads and HSV-1.
Many viruses, including adenoviruses (Ads) and herpesvi-
ruses, spread by intracellular transport within infected host
cells, thus increasing the viral load in target organs and possibly
causing severe disease (44). The 51 human Ad serotypes—
classified into six species (A to F)—have distinct tropisms (19).
For example, Ad type 2 (Ad2) and Ad5 (species C) and Ad3
(species B) are associated with upper-airway infections. Other
serotypes are linked to epidemic keratoconjunctivitis (species
D), pneumonia (species E), enteric infections (species A and
F), or infections of hematopoietic cells (41). The Herpesviridae
family consists of the alpha-, beta- and gammaherpesviruses.
Like Ads, alphaherpesviruses, including herpes simplex virus
type 1 (HSV-1), infect different cell types both in cultures and
in their hosts. After infection of mucosal or damaged cutane-
ous epithelium, these neurotropic viruses establish latent in-
fections, primarily in sensory ganglia, that, upon reactivation,
lead to recurrent epidermal lesions (40, 55). The ability to
infect a broad range of postmitotic cells has made both Ads
and herpesviruses useful gene delivery vehicles (21) that are
currently being evaluated in clinical trials (29, 39). For their
application as therapeutic vectors and to identify new potential
targets for antiviral therapy, it is crucial to understand how the
genomes are targeted to the nucleus.
The entry mechanisms for Ads and herpesviruses have been
well studied. Ads are internalized by receptor-mediated endo-
cytosis that is dependent on F actin and leave the endosomal
pathway at various sites (recently reviewed in reference 11).
The species C Ads, including Ad2 and Ad5, exit from a slightly
acidic compartment of pH 6 at about 10 min postentry (16, 42),
whereas Ad7 (species B) has been reported to escape from
acidic late endosomes and lysosomes (32). In contrast, HSV-1
delivers its capsids into the cytosol upon fusion of the viral
envelope with the plasma membrane (45, 46). Both viruses
then target their capsids to the cell nucleus, uncoat, and inject
the enclosed linear double-stranded DNA genomes through
the nuclear pores into the nucleoplasm for replication (14, 35,
53).
A number of electron microscopy studies have shown that
cytoplasmic capsids of both species C Ads and alphaherpesvi-
ruses can associate with microtubules (MTs) (5, 10, 27, 28, 31,
37, 45, 47, 57). Moreover, time-lapse fluorescence microscopy
experiments of fluorophore-tagged Ads have demonstrated
that Ads move along linear tracks of MTs (25, 26, 49). The
motility of incoming particles is bidirectional, toward and away
from the nucleus, but the overall motilities are toward the
minus ends of MTs and require the major minus-end-directed
motor dynein and the cofactor dynactin. If MTs are depoly-
merized with nocodazole (NOC), then the long-range linear
motilities cease, the remaining short-range transport has no
directional control and, most importantly, the efficiency of Ad2
DNA delivery is strongly reduced, as indicated by fluorescence
in situ hybridization assays (48, 49).
Similar results have been reported for alphaherpesviruses.
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MT-depolymerizing agents block HSV-1 infections in cultures
and in animal models (17, 22, 45, 51, 52). Moreover, incoming
HSV-1 capsids colocalize with dynein and dynactin, and trans-
port to the nucleus is reduced by the dynein inhibitors erythro-
9[3-(2-hydroxynonyl)]adenine and dynamitin (6a, 22, 45). Ax-
onal herpesvirus transport occurs at rates of 0.5 to 3.5 m/s,
with peak velocities of up to 5 m/s (1, 28, 37, 43); viral
structures are transported bidirectionally along linear tracks
with high processivity over distances of up to 20 m, as dem-
onstrated by video microscopy with green fluorescent protein
(GFP)-tagged mutants (1, 43; A. Wolfstein et al., unpublished
data).
In a recent article, it was proposed that Ad5 infections do
not require MTs (8). We therefore decided to conduct a quan-
titative analysis of Ad5-mediated gene expression and Texas
Red (TR)-coupled Ad2 (Ad2-TR) subcellular localization in
cells depleted of MTs; as an independent control, we included
HSV-1. Our results show that the large majority of Ad2-TR,
Ad5, and HSV-1 particles utilize intact MTs to reach the nu-
cleus in order to infect nonpolarized epithelial cells.
MATERIALS AND METHODS
Cells and reagents. Immortalized human adenocarcinoma-derived alveolar
epithelial A549 cells (ATCC CCL-185) were maintained in Dulbecco’s modified
Eagle’s medium (Gibco Invitrogen, Basel, Switzerland) containing 7% Clone III
serum (HyClone; Socochim, Geneva, Switzerland) and 1% nonessential amino
acids, 2 mM glutamine, 100 U of penicillin/ml, and 0.1 mg of streptomycin/ml (all
from Gibco-BRL). PtK2 cells (ATCC CCL-56) and BHK-21 cells (ATCC CCL-
10) were grown in 10% and Vero cells (ATCC CCL-81) were grown in 7.5% fetal
calf serum containing minimal essential medium, 2 mM glutamine, nonessential
amino acids and, for Vero cells, 100 U of penicillin/ml and 100 g of strepto-
mycin/ml. All cell lines were cultured in a humidified 5% CO2–air atmosphere.
NOC (Sigma) and paclitaxel (Calbiochem-Novabiochem or Sigma) were dis-
solved as 1,000-fold stocks in dimethyl sulfoxide (DMSO) and used as indicated
below. For the immunofluorescence experiments, we used preadsorbed rabbit
polyclonal antibodies raised against DNA-containing capsids (anti-heavy chain
[HC]) or empty capsids (anti-light chain [LC]) to detect incoming viral capsids (4,
45). MTs were labeled with a mouse monoclonal antibody against -tubulin
(N357; Amersham, Little Chalfont, United Kingdom) (2).
Ad infection and gene expression. Ad2 was purified and coupled to TR as
described previously to yield Ad2-TR (33). This virus was as infectious as the
nonlabeled parent virus, as determined by plaque assays with A549 cells. The
Ad5 derivative AE18, lacking the E1 and E3 regions, expressed lacZ from the
cytomegalovirus (CMV) major promoter (provided by E. Vigne, Institut G.
Roussy, Villejuif, France) (54). Luc-Ad5, lacking E1 and E3, expressed luciferase
from a CMV promoter inserted into the E1 region (kindly provided by S. Hemmi
and D. Serena, University of Zu¨rich). In brief, this virus was constructed from a
pPoly plasmid backbone (3) and plasmid pTG-H5 DL324 (kindly supplied by S.
Rusconi, University of Fribourg, Fribourg, Switzerland). Cells were seeded in
24-well dishes (Costar; Integra Biosciences) or on glass coverslips 1 to 2 days
before the experiment. Prior to infection, 60 to 90% confluent cells were exposed
to NOC in DMSO or just DMSO alone in Dulbecco’s modified Eagle’s medium
for 1 h and then were infected with AE18 at 100 to 10,000 physical particles per
cell at 37°C. At various times after the addition of the virus, cells were either
analyzed for their viability or lysed, and lysates were assayed for -galactosidase
(-Gal) activity and protein content. -Gal activity was measured by a -Gal
enzyme assay (Promega Corporation). The cells in 1 well of a 24-well dish were
washed with phosphate-buffered saline (PBS) at 7, 24, 32, or 48 h postinfection
(p.i.) and lysed in 400 l of reporter lysis buffer (Promega) for 15 min at room
temperature under slowly rocking conditions. The lysates were centrifuged in a
microcentrifuge at 4°C for 2 min, and 30 l of the supernatants was mixed with
the same volume of 2 enzyme reaction buffer (Promega) and incubated at 37°C
for various times. The reactions were stopped by the addition of 100 l of 1 M
sodium carbonate. The absorbance was read at 420 nm with a spectrophotometer
(MRX microplate reader; Dynatech Laboratories; BioLogics, Gainesville, Va).
The background activity of noninfected A549 cells was subtracted from the
measurements. The protein content of each lysate was measured with Micro
BCA protein assay reagent (Pierce), and the results are expressed as enzymatic
units per milligram of protein per minute. The luciferase activity of infected cells
was determined with cell lysates at 7 h p.i. by using a commercial assay system
(Promega). The cells in 1 well of a 24-well dish were washed with PBS and lysed
in 400 l of reporter lysis buffer. The centrifuged lysates (20 l) were placed in
an opaque 96-well plate for luciferase activity measurements with a Multilabel
Counter (Wallac Victor2 1420; Perkin-Elmer), which injected 50 l of luciferase
assay reagent into each well.
HSV-1 infection and gene expression. Wild-type HSV-1 strain F (ATCC VR-
733) and mutant strain [KOS]tk12 were amplified and purified as described
previously (45). Immediate-early viral gene expression was analyzed by using
mutant [KOS]tk12, which lacks the viral thymidine kinase gene and encodes the
enzyme -Gal under the control of the immediate-early ICP4 promoter of
HSV-1 (kindly provided by P. Spear, Northwestern University, Chicago, Ill.)
(56). PtK2 cells were cultured in 24-well plates at a density of 4  104 to 5  104
cells per well for 1 day. They were pretreated with NOC or paclitaxel in DMSO
or just DMSO alone for 1 h, cooled to 4°C, and incubated with virus for 2 h as
described elsewhere (6a, 45). Unbound virus was removed by repeated washing
in PBS, and the cells were further incubated in culture medium at 37°C.
At different times, the cells were lysed with 0.5% Triton X-100 (TX-100) in
PBS containing 1 mg of bovine serum albumin/ml and protease inhibitors at 37°C
for 15 min. Lysates were then incubated with 3.5 mg of o-nitrophenyl--D-
galactopyranoside/ml in 73 mM Na2HPO4–16 mM NaH2PO4–0.2 mM KH2PO4–
0.4 mM KCl–17 mM NaCl. The enzymatic activity of -Gal was measured after
about 2 h at 420 nm by using a plate reader (Spectra Count microplate photom-
eter; Packard Instrument Company, Meriden, Conn.). On a parallel plate, cells
were fixed with 3% (wt/vol) paraformaldehyde (PFA) in PBS for 20 min, washed
with water, and then stained with 0.25 mg of crystal violet/ml in 5% ethanol for
10 min to quantify the amount of cells present after different treatments. After
several washes in water, the plates were dried, and the bound crystal violet was
dissolved in 100% ethanol and quantified by measuring the optical density at 590
nm (17). Crystal violet staining gave a linear signal over cell concentrations
ranging from at least 3  103 to 3  105 cells per well (data not shown).
Quantification of subcellular viral targeting. To analyze the subcellular dis-
tribution of incoming HSV-1 capsids, Vero or PtK2 cells were infected in the
presence of 0.5 mM cycloheximide. The cells were then (i) fixed with 100%
methanol for 4 min at 20°C after a 10-s preextraction in 0.5% TX-100–80 mM
PIPES-KOH (pH 6.8)–2 mM MgSO4–10 M paclitaxel to visualize MTs and
capsids as described previously (45), (ii) fixed and permeabilized simultaneously
with PHEMO-fix (3.7% [wt/vol] PFA, 0.05% [wt/vol] glutaraldehyde, and 0.5%
TX-100 in PHEMO-buffer [see below]) for 10 min and washed with PHEMO-
buffer (68 mM PIPES-KOH [pH 6.9], 15 mM EGTA, 3 mM MgCl2, 10% DMSO)
to label MTs, or (iii) fixed with 3% (wt/vol) PFA in PBS for 20 min and then
permeabilized with 0.1% (vol/vol) TX-100 for exactly 5 min. The remaining PFA
was inactivated by incubating the cells with 50 mM NH4Cl–PBS for 10 min.
Immunolabeling was performed as described elsewhere (6a, 45). The cells were
examined either with a modified confocal microscope (model MRC600; Bio-Rad
Laboratories, Hercules, Calif.) attached to an Axiovert microscope (Carl Zeiss,
Inc., Thornwood, N.Y.) with separate filters for each fluorochrome or with a
Leica SP1 microscope (63 oil-immersion objective; numeric aperature, 1.32)
with UV excitation at 351 and 364 nm and with fluorescein isothiocyanate (468
nm), TR (568 nm), and long-pass emission filters in sequential recording mode
at a section thickness of 0.5 m. Images were processed with Photoshop 5.0
(Adobe). The subcellular distributions of Ad2-TR and HSV-1 (immunolabeled
with an anti-LC antibody) were determined by quantitative fluorescence micros-
copy of cells fixed with PHEMO-fix by the procedure described earlier (33).
Cell viability assay. Cell viability was assessed with a live/dead viability/cyto-
toxicity two-color fluorescence assay (L-3224; Molecular Probes). This assay
measures intracellular esterase activity with the cell-permeable substrate Cal-
cein-AM, which is converted by live cells to the fluorescent polyanion calcein
(excitation, 495 nm; emission, 515 nm), which is retained in living cells by the
intact plasma membrane. In addition, we used the non-cell-permeating DNA dye
ethidium homodimer-1 (EthD-1) (excitation, 495 nm; emission, 635 nm), which
is detected in cells with compromised membranes, i.e., dead cells. In this assay,
live cells have a green fluorescent cytoplasm but no EthD-1 signal, whereas dead
cells lack green fluorescence and are stained with EthD-1. The assays were
performed by washing cells once with PBS and incubating them with Calcein-AM
(0.8 M for A549 cells and 0.2 M for PtK2 cells) and EthD-1 (0.8 M for A549
cells and 0.1 M for PtK2 cells) in Hanks’ medium (Gibco-BRL) at 37°C for 15
min. Cells were washed with Hanks’ medium, and fluorescence was analyzed with
a Leica inverted fluorescence microscope equipped with a 63 oil-immersion
objective (numeric aperture, 1.32), a band-pass excitation filter, and a double-
pass emission filter as described earlier (49). Images were recorded with Meta-
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Morph software (Universal Imaging Corporation) and batch processed with
Photoshop 5.0.
RESULTS
Glotzer et al. (8) recently suggested that Ad5 infection of the
epithelial cell line A549 occurred in the absence of MTs (8),
contradicting earlier results (26, 49). A reexamination of the
role of MTs in Ad infection was therefore warranted.
NOC is an inhibitor of Ad5 infection. We first analyzed
adenovirus transgene expression in A549 cells containing in-
tact or disrupted MTs. Cells were preincubated with different
concentrations of the MT-depolymerizing agent NOC at 37°C
for 60 min (20) and then were inoculated with -Gal-express-
ing Ad5 (-Gal–Ad5) at 10,000 physical particles per cell,
equivalent to about 300 associated particles per cell (48). The
particle-to-PFU ratio is estimated to be on the order of 20 to
100, corresponding to 3 to 15 bound infectious particles per
cell (18). -Gal activity was measured in cell lysates at 7 h p.i.,
the earliest time point that gave a reliable reading. The lowest
concentration of NOC (0.2 M) had no effect on -Gal ex-
pression, whereas 2 M NOC resulted in 40% inhibition and
20 M NOC resulted in greater than 80% inhibition compared
to the results obtained for untreated cells (Fig. 1A). The latter
conditions are sufficient to completely depolymerize MTs in
Vero cells (45) (Fig. 4A, panel d), HeLa cells (49), or A549
cells (Fig. 2A, panel e), whereas PtK2 cells require 50 M
NOC (data not shown). A549 cells were therefore treated with
20 M NOC, and -Gal activity was measured at 7, 24, and
48 h after inoculation with 1,000 and 10,000 particles per cell.
In both instances, there was a severe reduction of gene expres-
sion, with 85% inhibition at 7 h p.i. and 50 to 70% inhibition at
24 and 48 h p.i. (Fig. 1B). The effect of NOC was reversible, as
indicated by washing the cells with drug-free medium at 180
min p.i. and incubating them for another 4 h in the absence of
drug (Fig. 1C). When NOC was added at 3 h p.i., when a large
fraction of the incoming DNA had been delivered to the nu-
cleoplasm (49, 53), there was only marginal inhibition of viral
gene expression. This result indicated that most of the infec-
tious particles had reached the nucleus at 3 h p.i. In contrast,
when NOC was present throughout the infection, -Gal ex-
pression was reduced by 85% compared to that in control cells.
We next tested the effect of NOC on the gene expression of
a different virus, Luc-Ad5. This strategy enabled us to reduce
the viral load to 10 particles per cell and still measure trans-
gene activity as early as 7 h p.i. Consistent with the -Gal
activity results, 20 M NOC reduced luciferase activity by 50 to
70% at 10, 100, 1,000, or 10,000 particles per cell (Fig. 1D).
Importantly, the assay was linear in this range. We next ana-
lyzed whether NOC affected the viability of the cells either in
the presence or in the absence of -Gal–Ad5. Cells were pre-
treated with NOC (20 M) for 1 h, infected or not infected
with Ad5, and then stained with the vital dyes Calcein-AM and
EthD-1. Intact live cells excluded EthD-1 and cytosolic ester-
ases hydrolyzed Calcein-AM, thus generating green fluores-
cent Calcein. All cells on the coverslip were EthD-1 negative
and Calcein positive (Fig. 1E, panels a to f), unlike cells that
had been treated with methanol (Fig. 1E, panels g to i). Im-
portantly, there was no cell loss from the coverslips, as verified
by differential interference contrast imaging (Fig. 1E, panels c,
f, and i).
NOC blocks the nuclear accumulation of Ad2-TR. If NOC is
an early inhibitor of Ad5 infection, then it could have an effect
on genome trafficking. To visualize cytoplasmic particles, we
used fluorescent Ad2-TR containing two to four TR molecules
per hexon trimer, corresponding to 200 to 400 TR molecules
per virion (13, 33). Importantly, this virus is as infectious as
unlabeled virus and is not aggregated, as judged by electron
microscopy of negatively stained particles and population anal-
ysis of viral fluorescence (33). A recent study showed that the
DNA genome of purified Ad2 separates from the capsid at the
nuclear pore complex (NPC) and that the remainder of the
capsid tends to form aggregates or becomes undetectable (53).
A549 cells were treated with different concentrations of NOC
as described above, and Ad2-TR was bound to the cell surface
at 4°C for 1 h to synchronize the infection at 37°C in the
presence or in the absence of the drug. One set of cells was
fixed at 75 min p.i. and stained for MTs. Clearly, increasing
amounts of NOC progressively depolymerized MTs (Fig. 2A),
whereas DMSO alone had no effect on the morphology of the
MT network. By use of a fast Fourier transformation algo-
rithm, viral fluorescence was quantitated in the cell periphery,
the cytoplasmic area, and the nucleus, including a perinuclear
region of 1.5 m (33). While control cells had low peripheral
and cytoplasmic but high nuclear fluorescence signals (less
than 1 but more than 5 fluorescence units per unit area,
respectively), 20 M NOC-treated cells showed almost no
nuclear accumulation of Ad2-TR (1.6 fluorescence units per
unit area); instead, there was a significant increase in the pe-
ripheral and cytoplasmic fluorescence intensity (P 0.01) (Fig.
2B).
We next carried out a time course experiment either in the
absence or in the presence of 20 M NOC. As expected, the
nuclear and perinuclear fluorescence of control cells increased
to greater than 5 fluorescence units per unit area at 75 min p.i.
compared to 1 unit at 0 min p.i., while the peripheral and
cytoplasmic Ad2-TR fluorescence decreased to less than 0.2
unit (Fig. 2C). At 150 min, however, the viral capsid load in the
nuclear and perinuclear area decreased to less than two, in-
dicative of viral disassembly, which peaks at between 150 and
180 min p.i. (14, 53). The strong decrease in nuclear Ad2-TR
particles coincided with a robust increase in peripheral and
cytoplasmic virus, suggesting that viral capsids or fragments
were transported back to the periphery. Interestingly, the nu-
clear fluorescence increased again at 300 and 420 min p.i. (P 
0.05) and the peripheral fluorescence decreased. These results
suggested a second transport wave of Ad2-TR toward the
nucleus. This experiment confirms that in control cells, our
measurements of fluorescent capsids are quantitative at least
until 75 min p.i., the onset of capsid disassembly.
The subcellular virus distribution in NOC-treated cells was
fundamentally different from that in control cells. At up to 150
min p.i., the viral capsid load in the nuclear and perinuclear
region was no different from the charge at 0 min p.i.; i.e., there
was no enrichment of Ad2-TR near the nucleus (Fig. 2D). The
virus concentrations in the cytoplasm and the periphery were
slightly reduced. Interestingly, we found a small but significant
accumulation of Ad2-TR near the nucleus (P  0.01) at 300
min p.i. Approximately 10% of the viral fluorescence appar-
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FIG. 1. Ad5-mediated gene expression requires intact MTs. (A to D) A549 cells were not treated or treated with the indicated concentrations
of NOC for 1 h and then infected with -Gal–Ad5 (A to C) or Luc-Ad5 (D) for the indicated times at 37°C. Gene expression was normalized to
that of drug-free infected cells (A and B) or is reported as enzymatic units per milligram of protein per minute (C) or relative light units (D) at
room temperature. The reversibility of the effects of NOC was tested by washing out the drug at 180 min, and the postentry effects of NOC were
assessed by adding the drug at 180 min p.i. (C). Error bars indicate standard errors of the means. (E) Toxicity of NOC for -Gal–Ad5-infected
cells (a to c) and noninfected cells (d to f) at 7 h p.i. with ethidium bromide (a, d, and g) and calcein (b, e, and h) staining and with Nomarksi (Nom)
differential interference contrast imaging (c, f, and i). Note that dead cells were EthD-1 positive and calcein negative; see, e.g., methanol (MetOH,
70% for 30 min)-treated cells (g to i). NOC-treated or infected cells were all alive. Bar, 40 m.
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ently reached the nucleus in the absence of MTs. At least some
nuclear capsids must have been genome-containing particles,
since we detected viral gene expression in the presence of NOC.
The reduction in the nuclear capsid signal at 420 min p.i. might
have been due to capsid disassembly. In summary, these results
indicate that more than 90% of the incoming Ad2-TR did not
reach the nucleus in the absence of MTs and that this transport
block strongly reduced viral gene expression.
FIG. 2. NOC blocks nuclear targeting of Ad2-TR in A549 cells. Ad2-TR was cold bound to A549 cells not pretreated or pretreated with
different concentrations of NOC. Cells were warmed for the indicated times at 37°C in the presence or in the absence of NOC and then fixed with
PHEMO-fix. (A) Entire set of projected confocal laser scanning microscopy sections of representative cells depicting Ad2-TR (red), MTs (green),
and the nucleus (4,6-diamidino-2-phenylindole; dark blue). Note the disappearance of the MTs with increasing concentrations of NOC and the
lack of nuclear accumulation of Ad2-TR. Bar, 10 m. (B) Quantification of the subcellular localization of Ad2-TR in the periphery, the cytoplasm,
and the nuclear and perinuclear region of cells treated with different concentrations of NOC (n, number of cells analyzed). (C) Quantification of
the subcellular localization of Ad2-TR in A549 control cells over time. Note that the nuclear transport of Ad2-TR peaks at 80 to 90 min p.i., with
corresponding reductions in peripheral and cytoplasmic particles. (D) Quantification of the subcellular localization of Ad2-TR in the absence of
MTs (NOC treatment). Note the lack of nuclear transport at times before 200 min p.i. and the slight increase in nuclear accumulation at 300 min
p.i. Error bars indicate standard errors of the means.
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NOC blocks HSV-1-mediated gene expression. MTs are a
major intracellular trafficking route of alphaherpesviruses. We
therefore tested the effect of NOC on HSV-1 gene delivery
using the expression of -Gal activity controlled by the viral
immediate-early promoter of ICP4. PtK2 cells were pretreated
with different concentrations of NOC, incubated with HSV-1
[KOS]tk12 in the cold, infected in the presence or in the
absence of drug at 37°C for 4 h, and analyzed for -Gal activity.
The results clearly indicate that NOC is a dose-dependent
inhibitor of HSV-1 infection (Fig. 3A). The maximal inhibition
of approximately 90% was obtained with 25 M NOC. This
effect was due neither to cell loss, as indicated by cell quanti-
fication with crystal violet, nor to cell death, as measured by the
live/dead assay (data not shown). We next analyzed the effect
of 25 M NOC on HSV-1 infection in a time course experi-
ment at multiplicities of infection (MOIs) of 2 and 10 from 3 to
7 h p.i. Under all conditions, NOC inhibited viral gene expres-
sion in the range of 80 to 90% (Fig. 3B). However, the inhi-
bition was not complete. At an MOI of 10, there was a modest
increase in gene expression from 3 to 7 h p.i., indicating that a
small fraction of infectious virus had reached the nucleus in-
dependently of MTs.
NOC inhibits nuclear targeting of incoming HSV-1. We next
tested to what extent NOC affected MTs. Vero cells were
preincubated with different concentrations of NOC for 1 h,
incubated in the cold with HSV-1, and warmed in the presence
or in the absence of drug for 2 h. The highest concentration of
NOC (20 M) completely depolymerized MTs and led to a
random cytoplasmic localization of HSV-1 capsids (Fig. 4A,
panel d). In the absence of drug, however, the MT network was
intact and incoming HSV-1 localized predominantly to the
nucleus (Fig. 4A, panel a). Intermediate concentrations of
NOC (0.4 and 2 M) had partial effects on MTs and HSV-1
nuclear targeting (Fig. 4A, panels b and c).
To assess the effect of NOC on the subcellular trafficking of
HSV-1, we quantitated viral capsid fluorescence in the periph-
ery, the cytoplasm, and the nuclear and perinuclear region by
using the same method as that used for Ad2-TR. In the ab-
sence of drug, there was a strong enrichment of HSV-1 near
the nucleus and a significant decrease in the peripheral and
cytoplasmic viral load at 120 and 180 min p.i. (P  0.01) (Fig.
4B). NOC, however, blocked the nuclear accumulation as well
as the cytoplasmic reduction of HSV-1 at 120 and 180 min p.i.,
compared to the results obtained at 30 min p.i., but did not
affect the reduction of virus in the periphery (Fig. 4C). These
results suggested that viral trafficking through the cortex was
independent of MTs, unlike further cytoplasmic transport,
which largely required intact MTs. This conclusion was further
supported by experiments with the MT-stabilizing drug pacli-
taxel (10 M), which allowed a strong enrichment of HSV-1
near the nucleus, although this enrichment was slightly less
pronounced than that in drug-free cells. Accordingly, paclitaxel
had only minimal effects on the expression of -Gal (average
inhibition, 20 to 30%). Significantly, paclitaxel did not inhibit
the transport of virus through the cell periphery (Fig. 4D). We
conclude that HSV-1 capsid transport occurs on stabilized
MTs, suggesting that it does not depend on MT treadmilling or
dynamic instability.
DISCUSSION
Using quantitative subcellular localization of incoming viral
capsids and quantification of viral gene expression in the ab-
sence or in the presence of NOC, an MT-depolymerizing
agent, we found that MTs play a crucial role in delivering Ad
and HSV-1 genomes to the nuclei of epithelial cells. The NOC
inhibition was reversible (45, 49; this study), NOC had no effect
on cellular gene expression (data not shown), and only minor
FIG. 3. Intact MTs are required for HSV-1 mediated gene expres-
sion. (A) PtK2 cells were treated with DMSO (control) or NOC for 1 h
at 37°C and then incubated with the -Gal-expressing HSV-1 strain
[KOS]tk12 at 4°C for 2 h (MOI, 10). The unbound viruses were re-
moved, and the cells were shifted to 37°C in the presence or in the
absence of NOC to initiate infection. Cells were lysed at 4 h p.i., and
the amount of -Gal was quantitated (squares). Cells on parallel
dishes were quantified by using the binding of crystal violet (circles).
The means and standard deviations for duplicate samples are shown.
Note that with increasing NOC concentrations, the amount of imme-
diate-early viral gene expression was inhibited. (B) Time course of
HSV-1 gene expression. Cells were infected in the absence (filled
symbols) or in the presence (open symbols) of MTs with HSV-1
[KOS]tk12 (MOI of 2 [triangles] or MOI of 10 [squares]), lysed at
different times p.i., and analyzed for -Gal expression (absorbance at
420 nm). At both MOIs and at all times tested, NOC clearly reduced
immediate-early viral gene expression. The crystal violet assay showed
no significant loss of cells under these conditions (5%) (data not
shown).
VOL. 76, 2002 MTs ARE REQUIRED FOR Ad AND HSV-1 INFECTIONS 9967
FIG. 4. NOC inhibits the nuclear targeting of HSV-1 in Vero and PtK2 cells. (A) Vero cells were infected in the absence or in the presence
of different concentrations of NOC with 50 PFU of HSV-1 per cell for 2 h and then fixed in methanol after preextraction. Samples were stained
with anti-HC (green) and antitubulin (red) and analyzed by confocal laser scanning microscopy. Note the disappearance of the MTs with increasing
concentrations of NOC and the lack of nuclear HSV-1 capsids. (B to D) Quantification of subcellular localization of HSV-1 in PtK2 cells infected
with 80 PFU per cell in the absence of drug (B), in the presence of 50 M NOC (C), or in the presence of 10 M paclitaxel (D). Cells were fixed
at 30, 120, or 180 min p.i. and labeled with anti-LC. n, number of cells. Error bars indicate standard errors of the means. MTs in Vero cells were
completely depolymerized at lower concentrations of NOC than were those in PtK2 cells (data not shown).
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effects on viral gene expression after particle transport to the
nucleus had occurred (this study). We therefore concluded, as
others have before, that NOC is not a general inhibitor of
transcription or translation but acts predominantly on the MT
network (20).
MTs are required for viral capsid transport. There are sev-
eral explanations for why NOC treatment did not completely
inhibit the delivery of viral DNA into the nucleus. Virions can
enter from the plasma membrane proximal to the nuclear
envelope. These particles are separated from the nucleus by
only a few micrometers. Another possibility is that cytosolic
virions use an MT-independent transport mechanism, such as
an actin-based system (36, 38); that they are transported on
short, randomly oriented MT filaments resistant to NOC; or
that they exploit diffusion. All of these processes would stop
when the capsid binds to the NPC, leading to particle enrich-
ment at the nucleus. Clearly, Ad2-TR particles are able to
explore a few micrometers of cytosolic space in the absence of
MTs (8, 49); thus, particles entering from the plasma mem-
brane proximal to the nucleus will most likely not require MTs
to reach the NPC. This means that careful kinetic measure-
ments are necessary to reveal the role of any cytoplasmic trans-
port system.
We predict that cells that are particularly small will be in-
fected in the absence of MTs if enough time is allowed. This
scenario may, in fact, have obscured the role of MTs in Ad
infection (5, 50). Our measurements here reveal that nuclear
transport of both Ad2 and HSV-1 from distal areas to the
nucleus is blocked in the absence of MTs. Since HSV-1 infec-
tion of polarized neuronal cells in a compartmentalized culture
absolutely depends on MTs (22), the results obtained with
HSV-1 confirm that the quantitative imaging procedures that
we used for Ad2 and HSV-1 are reliable. The role of MTs in
cytoplasmic particle trafficking is in agreement with the results
of studies of endocytic and exocytic membrane traffic and ax-
onal transport, where NOC was found to be a kinetic rather
than an absolute inhibitor of membrane traffic (9, 24).
Capsid transport and viral gene expression required neither
MT treadmilling nor the dynamic instability of MTs, since
paclitaxel (at concentrations of 180 nM to 10 M) had only
slight effects on Ad2 and HSV-1 infections. Likewise, cells
expressing MAP4, which stabilizes the MT network (34), trans-
ported Ad2 to the nucleus even faster than control cells (49);
low concentrations of paclitaxel or NOC (5 nM), suppressing
MT dynamics without depolymerizing MTs, have similar ef-
fects (6, 7). Thus, preferentially stabilized MTs effectively sup-
port viral transport to the nucleus. A further indication that
Ad2 utilizes MTs for nuclear targeting came from experiments
in which transport directionality was controlled. Ad2 was
found to stimulate two distinct signaling pathways which both
enhance the MT-dependent minus-end-directed transport of
Ad2 capsids (48). In the absence of stimulation, viral motility
was directed toward the cell periphery, dependent on intact
MTs.
Live imaging of MT-dependent and independent Ad trans-
port. Glotzer et al. (8) recently questioned the role of MTs in
Ad5 infection. They traced incoming Ad5 that contained a
GFP-tetracycline repressor fusion protein (GFP-TetR) bound
to operator sequences in the Ad5 DNA genome but were not
able to detect fast retrograde motions of GFP-TetR-tagged
Ad5, unlike other reports with fluorophore-tagged Ad (26, 48,
49).
There are several not mutually exclusive possibilities for why
Glotzer et al. (8) missed the fast minus-end-directed motility of
Ad. The first possibility involves temperature. Glotzer et al. (8)
used room temperature for their live experiments, whereas we
always conducted our live experiments at 37°C with a temper-
ature-controlled sample holder. The second possibility involves
longer intervals between subsequent frames. While we re-
corded frame intervals of 1 to 2 s, Glotzer et al. (8) used frame
intervals of 3 to 5 s. Longer intervals make it less likely that
high-speed elementary motion steps will be detected. The third
possibility involves imaging with PBS. For their tracing exper-
iments, Glotzer et al. (8) used PBS lacking glucose and other
nutrients, whereas we used growth medium without serum
(and sometimes also without phenol red). Depending on the
duration of the incubation, PBS may reduce the ATP levels in
the cells. Interestingly, the vast majority of the particles (about
15 to 20 particles, corresponding to about 95%) in the study of
Glotzer et al. (8) were apparently nonmotile during the 14-s
period depicted in their Fig. 4A. This result is again in contrast
to our imaging of 40 to 60% motile particles (7, 48, 49). The
fourth possibility involves imaging at shorter wavelengths and
longer exposure times. Glotzer et al. (8) used GFP-tagged Ad
and thus had to use an excitation beam of about 500 nm. Their
exposure times were between 1 and 1.5 s, whereas our expo-
sure times were between 0.2 and 0.4 s, i.e., four or five times
shorter and thus less phototoxic. The published images in the
study of Glotzer et al. (8) demonstrate photobleaching effects
after as few as five frames (their Fig. 4A). Phototoxicity is
known to affect the viability of cells; thus, their results are
difficult to compare with our data. We imaged the TR fluoro-
phore with a 595-nm excitation and were able to record several
hundred subsequent frames (48, 49). The fifth possibility in-
volves statistical analysis. Due to the limited data set that
Glotzer et al. (8) were able to collect, their statistical analysis
was limited. They processed between 20 and 218 frames per
assay, whereas we included several thousand frames per assay.
Thus, our standard deviations of the mean are smaller and the
differences between various conditions (e.g., plus or minus
NOC) are highly significant for our measurements (one-sided
t tests). The sixth possibility involves the subcellular area of
particle tracing. Figure 4 in the study of Glotzer et al. (8) shows
that 8 out of 11 traced particles were in a region proximal to
the nucleus, i.e., separated by less than 10 m from the nuclear
envelope. The perinuclear region is known to be elevated com-
pared to the flat periphery. Motility in this region can also
occur along the z axis and thus toward and away from the
detector; i.e., the observed velocities in the perinuclear region
might have been underestimated. Many studies, including ours,
have therefore traced organelles (23) and viruses (reviewed in
reference 12) in the peripheral flat regions of the cytoplasm
and have used cells that are extensively spread out (see, e.g.,
reference 30). The final possibility involves the nature of GFP-
TetR-tagged Ad particles. Glotzer et al. (8) used GFP-TetR-
tagged Ad5 in which GFP-TetR was bound to operator se-
quences in the genomic DNA. Using biochemical assays, they
demonstrated that the tag cofractionated with a viral DNA
binding protein at 30 min p.i., but the stability of this interac-
tion later in infection was not characterized. It is also unclear
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what fraction of the particles was recovered in their analysis at
30 min p.i., since the control fractionation sample at 0 min p.i.
was missing. They then performed all their fluorescence mo-
tility experiments at times between 30 and 80 min p.i.; thus, it
is unknown whether the tag was in fact still on the viral particle.
That the tag could prematurely dissociate from the DNA was
suggested by their observations that GFP-TetR was not found
to be imported into the nucleus but that viral DNA was ap-
parently imported. In addition, it is not known whether the
tagged DNA was completely packaged into the virion. If pack-
aging was incomplete, then it is possible that some of the DNA
dissociated from the capsid prior to capsid arrival at the nu-
cleus. The dissociated DNA might or might not have been
tagged with GFP-TetR and thus might have appeared as flu-
orescent puncta. It is likely that these puncta would have had
motilities different from those of our Ad2-TR.
Besides these important technical differences in the live flu-
orescence experiments, another major difference between the
study of Glotzer et al. (8) and our study is the effect of NOC on
the movement of particles to the nucleus. Glotzer et al. (8)
found no effect of NOC on the movement of GFP-TetR-
tagged Ad DNA. Given the limitations of their tracing exper-
iments, this result is not surprising. Glotzer et al. (8) measured
slow short-range transport in both control and NOC-treated
cells, i.e., MT-independent transport. Their static analysis,
however, showed that GFP-TetR-tagged particles were found
at the microtubule organizing center at 30 to 40 min p.i. when
MTs were present but not when they were absent. This finding
fully agrees with our findings and further supports the notion
that the live analyses of Glotzer et al. (8) had technical limi-
tations obscuring the detection of fast motility steps.
It is important that the fluorescent dots that we detected
with Ad2-TR correspond to single viral particles that have the
same infectivity as their “parental” nonlabeled particles (33).
Quantitative subcellular localization of capsids in static images
indicated that in control cells, about 65% of the Ad2-TR ac-
cumulates over the nuclear and perinuclear region at 90 min
p.i. (33). This finding is in good agreement with the Ad2-TR
motilities in epithelial and fibroblastic cells (e.g., HeLa cells,
rat kangaroo PtK2 cells, African green monkey TC7 cells, or
mouse embryo fibroblasts), which are biased toward the nu-
cleus and have net population speeds on the order of several
micrometers per minute (48, 49). Elementary motility events
were between 0.2 and 0.4 m/s and reached minus-end-di-
rected peak velocities of up to 2.6 m/s. Moreover, capsids
were transported over short ranges as well as long distances,
consistent with processive motor-driven motility. Overexpres-
sion of the p50 subunit of the dynactin complex or antidynein
antibodies indicated that the minus-end-directed MT motor
complex dynein-dynactin has a key function in transporting
Ad2 as well as HSV-1 to the nucleus (6a, 26, 49). We conclude
that MTs are instrumental for the trafficking of Ad2 and
HSV-1 particles to the nucleus.
NOC inhibits Ad and HSV-1 infections. Consistent with a
role of MTs in transporting infectious DNA to the nucleus, we
found viral gene expression to be significantly inhibited in cells
lacking MTs. These cells remained on the substratum and
showed no signs of leakiness, i.e., cell death. With different
viruses (Ad2, Ad5, and HSV-1), different cell lines (Vero,
PtK2, A549, and HeLa), different MT-depolymerizing agents
(vinblastine [45] and NOC [this study]), different genes (ICP4,
-Gal, and luciferase [45; this study]), different promoters
(HSV-1 ICP4 and CMV immediate early), and different MOIs
(from 2 to 100 PFU/cell), viral gene expression was in all
instances found to be inhibited by 50 to 90%.
Our results again contrast those of Glotzer et al. (8). These
authors reported data suggesting that NOC had no effect on
the expression of luciferase from transgenic Ad5 or on infec-
tion, as estimated by counting of immunostained cells express-
ing the immediate-early viral protein E1A. NOC also appeared
to have no effect on GFP expression encoded by Ad5, as
determined by counting of green fluorescent cells. While the
percentage of fluorescent cells can be easily determined, the
fluorescent signal may not be linear over a wide range of
protein concentrations. Measuring an enzymatic activity, such
as luciferase or -Gal, however, allows for unambiguous quan-
tification if the assay is performed within the linear range of
the enzymatic activity. Glotzer et al. (8) reported that 1,000
particles per cell gave an average of about 102 luciferase light
units at 4 h p.i., whereas 10 times as much virus (10,000 par-
ticles per cell) resulted in 5  104 light units. This value is
50-fold more than what would be expected if the measure-
ments followed linear kinetics. Moreover, there was essentially
no increase in the luciferase signal from 6 to 24 h p.i. with
10,000 particles per cell, suggesting that the assay had been
saturated.
In summary, we conclude that intact MTs and their associ-
ated motors support the transport of infectious Ad and HSV-1
particles to the nucleus and thereby enhance the kinetics of
infection. Based on earlier results (14, 15, 35, 45, 53), we argue
that the Ad and HSV-1 genomes remain enclosed in capsids
during their cytosolic passage to the nucleus. Only when these
capsids arrive at the NPC will they be disassembled and their
DNA released and imported into the nucleus for transcription
and replication.
ACKNOWLEDGMENTS
He´le`ne Mabit and Michel Y. Nakano contributed equally to this
work.
We thank S. Hemmi and D. Serena for generous gifts of Luc-Ad5,
I. Vigne and P. Yeh for Ad5 derivative AE18, P. Spear for HSV-1
[KOS]tk12, R. Eisenberg and G. Cohen for antibodies against HSV-1
capsids, R. Stidwill and P. Groscurth for confocal laser scanning mi-
croscopy imaging, and D. Meder (Hannover, Germany) for assistance
with the -Gal assay.
This work was supported by the Swiss National Science Foundation
and the Kanton Zu¨rich (support given to U.F.G.), as well as by the
German Research Council (DFG; grant SO403-1 to B.S.).
REFERENCES
1. Bearer, E. L., X. O. Breakefield, D. Schuback, T. S. Reese, and J. H. LaVail.
2000. Retrograde axonal transport of herpes simplex virus: evidence for a
single mechanism and a role for tegument. Proc. Natl. Acad. Sci. USA
97:8146–8150.
2. Blose, S. H., D. I. Meltzer, and J. R. Feramisco. 1984. 10-nm filaments are
induced to collapse in living cells microinjected with monoclonal and poly-
clonal antibodies against tubulin. J. Cell Biol. 98:847–858.
3. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M.
Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by
homologous recombination in Escherichia coli. J. Virol. 70:4805–4810.
4. Cohen, G. H., M. Ponce de Leon, H. Diggelmann, W. C. Lawrence, S. K.
Vernon, and R. J. Eisenberg. 1980. Structural analysis of the capsid polypep-
tides of herpes simplex virus types 1 and 2. J. Virol. 34:521–531.
5. Dales, S., and Y. Chardonnet. 1973. Early events in the interaction of ad-
enoviruses with HeLa cells. IV. Association with microtubules and the nu-
clear pore complex during vectorial movement of the inoculum. Virology
56:465–483.
9970 MABIT ET AL. J. VIROL.
6. Derry, W. B., L. Wilson, and M. A. Jordan. 1995. Substoichiometric binding
of taxol suppresses microtubule dynamics. Biochemistry 34:2203–2211.
6a.Do¨hner, K., A. Wolfstein, J. Prank, C. Echeverri, D. Dujardin, R. Vallee, and
B. Sodeik. 2002. Function of dynein and dynactin in herpes simplex capsid
transport. Mol. Biol. Cell 13:2559–2573.
7. Giannakakou, P., M. Y. Nakano, K. C. Nicolaou, A. O’Brate, J. Yu, M. V.
Blagosklonny, U. F. Greber, and T. Fojo. 2002. Enhanced microtubule-
dependent trafficking and p53 nuclear accumulation by suppression of mi-
crotubule dynamics. Proc. Natl. Acad. Sci. USA 99:10855–10860.
8. Glotzer, J. B., A. I. Michou, A. Baker, M. Saltik, and M. Cotten. 2001.
Microtubule-independent motility and nuclear targeting of adenoviruses
with fluorescently labeled genomes. J. Virol. 75:2421–2434.
9. Goldstein, L. S., and Z. Yang. 2000. Microtubule-based transport systems in
neurons: the roles of kinesins and dyneins. Annu. Rev. Neurosci. 23:39–71.
10. Granzow, H., F. Weiland, A. Jons, B. G. Klupp, A. Karger, and T. C.
Mettenleiter. 1997. Ultrastructural analysis of the replication cycle of pseu-
dorabies virus in cell culture: a reassessment. J. Virol. 71:2072–2082.
11. Greber, U. F. 2002. Signalling in viral entry. Cell Mol. Life Sci. 59:608–626.
12. Greber, U. F., and E. Carafoli. 2002. Signalling takes control of nucleo-
cytoplasmic transport. EMBO Rep. 3:410–414.
13. Greber, U. F., M. Y. Nakano, and M. Suomalainen. 1998. Adenovirus entry
into cells: a quantitative fluorescence microscopy approach. Methods Mol.
Med. 21:217–230.
14. Greber, U. F., M. Suomalainen, R. P. Stidwill, K. Boucke, M. Ebersold, and
A. Helenius. 1997. The role of the nuclear pore complex in adenovirus DNA
entry. EMBO J. 16:5998–6007.
15. Greber, U. F., P. Webster, J. Weber, and A. Helenius. 1996. The role of the
adenovirus protease in virus entry into cells. EMBO J. 15:1766–1777.
16. Greber, U. F., M. Willetts, P. Webster, and A. Helenius. 1993. Stepwise
dismantling of adenovirus 2 during entry into cells. Cell 75:477–486.
17. Hammonds, T. R., S. P. Denyer, D. E. Jackson, and W. L. Irving. 1996.
Studies to show that with podophyllotoxin the early replicative stages of
herpes simplex virus type 1 depend upon functional cytoplasmic microtu-
bules. J. Med. Microbiol. 45:167–172.
18. Horwitz, M. S. 1990. Adenoviridae and their replication, p. 1679–1721. In
B. N. Fields and D. M. Knipe (ed.), Virology, 2nd ed., vol. 1. Raven Press,
New York, N.Y.
19. Horwitz, M. S. 1996. Adenoviruses, p. 2149–2171. In B. N. Fields, D. M.
Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 1. Raven Press,
Philadelphia, Pa.
20. Jordan, M. A., and L. Wilson. 1999. The use and action of drugs in analyzing
mitosis. Methods Cell Biol. 61:267–295.
21. Kay, M. A., J. C. Glorioso, and L. Naldini. 2001. Viral vectors for gene
therapy: the art of turning infectious agents into vehicles of therapeutics.
Nat. Med. 7:33–40.
22. Kristensson, K., E. Lycke, M. Roytta, B. Svennerholm, and A. Vahlne. 1986.
Neuritic transport of herpes simplex virus in rat sensory neurons in vitro.
Effects of substances interacting with microtubular function and axonal flow
[nocodazole, taxol and erythro-9-[3-(2-hydroxynonyl)]adenine]. J. Gen. Vi-
rol. 67:2023–2028.
23. Ku¨nzi, V., M. Glatzel, M. Y. Nakano, U. F. Greber, F. van Leuwen, and A.
Aguzzi. Unhampered prion neuroinvasion despite impaired fast axonal
transport in transgenic mice overexpressing four-repeat tau. J. Neurosci., in
press.
24. Lane, J., and V. Allan. 1998. Microtubule-based membrane movement. Bio-
chim. Biophys. Acta 1376:27–55.
25. Leopold, P. L., B. Ferris, I. Grinberg, S. Worgall, N. R. Hackett, and R. G.
Crystal. 1998. Fluorescent virions—dynamic tracking of the pathway of ad-
enoviral gene transfer vectors in living cells. Hum. Gene Ther. 9:367–378.
26. Leopold, P. L., G. Kreitzer, N. Miyazawa, S. Rempel, K. K. Pfister, E.
Rodriguez-Boulan, and R. G. Crystal. 2000. Dynein- and microtubule-me-
diated translocation of adenovirus serotype 5 occurs after endosomal lysis.
Hum. Gene Ther. 11:151–165.
27. Luftig, R. B., and R. R. Weihing. 1975. Adenovirus binds to rat brain mi-
crotubules in vitro. J. Virol. 16:696–706.
28. Lycke, E., K. Kristensson, B. Svennerholm, A. Vahlne, and R. Ziegler. 1984.
Uptake and transport of herpes simplex virus in neurites of rat dorsal root
ganglia cells in culture. J. Gen. Virol. 65:55–64.
29. Markert, J. M., M. D. Medlock, S. D. Rabkin, G. Y. Gillespie, T. Todo, W. D.
Hunter, C. A. Palmer, F. Feigenbaum, C. Tornatore, F. Tufaro, and R. L.
Martuza. 2000. Conditionally replicating herpes simplex virus mutant, G207
for the treatment of malignant glioma: results of a phase I trial. Gene Ther.
7:867–874.
30. Matteoni, R., and T. E. Kreis. 1987. Translocation and clustering of endo-
somes and lysosomes depends on microtubules. J. Cell Biol. 105:1253–1265.
31. Miles, B. D., R. B. Luftig, J. A. Weatherbee, R. R. Weihing, and J. Weber.
1980. Quantitation of the interaction between adenovirus types 2 and 5 and
microtubules inside infected cells. Virology 105:265–269.
32. Miyazawa, N., R. G. Crystal, and P. L. Leopold. 2001. Adenovirus serotype
7 retention in a late endosomal compartment prior to cytosol escape is
modulated by fiber protein. J. Virol. 75:1387–1400.
33. Nakano, M. Y., and U. F. Greber. 2000. Quantitative microscopy of fluores-
cent adenovirus entry. J. Struct. Biol. 129:57–68.
34. Nguyen, H. L., S. Chari, D. Gruber, C. M. Lue, S. J. Chapin, and J. C.
Bulinski. 1997. Overexpression of full- or partial-length Map4 stabilizes
microtubules and alters cell growth. J. Cell Sci. 110:281–294.
35. Ojala, P. M., B. Sodeik, M. W. Ebersold, U. Kutay, and A. Helenius. 2000.
Herpes simplex virus type 1 entry into host cells: reconstitution of capsid
binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol.
20:4922–4931.
36. Pantaloni, D., C. Le Clainche, and M. F. Carlier. 2001. Mechanism of
actin-based motility. Science 292:1502–1506.
37. Penfold, M. E., P. Armati, and A. L. Cunningham. 1994. Axonal transport of
herpes simplex virions to epidermal cells: evidence for a specialized mode of
virus transport and assembly. Proc. Natl. Acad. Sci. USA 91:6529–6533.
38. Ploubidou, A., and M. Way. 2001. Viral transport and the cytoskeleton. Curr.
Opin. Cell Biol. 13:97–105.
39. Ries, S., and W. M. Korn. 2002. ONYX-015: mechanisms of action and
clinical potential of a replication-selective adenovirus. Br. J. Cancer 86:5–11.
40. Roizman, B., and D. M. Knipe. 2001. Herpes simplex viruses and their
replication, p. 1123–1183. In D. M. Knipe and P. M. Howley (ed.), Funda-
mental virology, 4th ed. Lippincott-Raven, Philadelphia, Pa.
41. Segerman, A., Y. F. Mei, and G. Wadell. 2000. Adenovirus types 11p and 35p
show high binding efficiencies for committed hematopoietic cell lines and are
infective to these cell lines. J. Virol. 74:1457–1467.
42. Seth, P., M. C. Willingham, and I. Pastan. 1985. Adenovirus-dependent
release of 51Cr from KB cells at an acidic pH. J. Biol. Chem. 259:14350–
14353.
43. Smith, G. A., S. P. Gross, and L. W. Enquist. 2001. Herpesviruses use
bidirectional fast-axonal transport to spread in sensory neurons. Proc. Natl.
Acad. Sci. USA 98:3466–3470.
44. Sodeik, B. 2000. Mechanisms of viral transport in the cytoplasm. Trends
Microbiol. 8:465–472.
45. Sodeik, B., M. W. Ebersold, and A. Helenius. 1997. Microtubule-mediated
transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell
Biol. 136:1007–1021.
46. Spear, P. G., R. J. Eisenberg, and G. H. Cohen. 2000. Three classes of cell
surface receptors for alphaherpesvirus entry. Virology 275:1–8.
47. Stidwill, R. S., and U. F. Greber. 2000. Intracellular virus trafficking reveals
physiological characteristics of the cytoskeleton. News Physiol. Sci. 15:67–71.
48. Suomalainen, M., M. Y. Nakano, K. Boucke, S. Keller, and U. F. Greber.
2001. Adenovirus-activated PKA and p38/MAPK pathways boost microtu-
bule-mediated nuclear targeting of virus. EMBO J. 20:1310–1319.
49. Suomalainen, M., M. Y. Nakano, K. Boucke, S. Keller, R. P. Stidwill, and
U. F. Greber. 1999. Microtubule-dependent minus and plus end-directed
motilities are competing processes for nuclear targeting of adenovirus.
J. Cell Biol. 144:657–672.
50. Svensson, U., and R. Persson. 1984. Entry of adenovirus 2 into HeLa cells.
J. Virol. 51:687–694.
51. Topp, K. S., K. Bisla, N. D. Saks, and J. H. Lavail. 1996. Centripetal
transport of herpes simplex virus in human retinal pigment epithelial cells in
vitro. Neuroscience 71:1133–1144.
52. Topp, K. S., L. B. Meade, and J. H. LaVail. 1994. Microtubule polarity in the
peripheral processes of trigeminal ganglion cells: relevance for the retro-
grade transport of herpes simplex virus. J. Neurosci. 14:318–325.
53. Trotman, L. C., N. Mosberger, M. Fornerod, R. P. Stidwill, and U. F. Greber.
2001. Import of adenovirus DNA involves the nuclear pore complex receptor
CAN/Nup214 and histone H1. Nat. Cell Biol. 3:1092–1100.
54. Vigne, E., I. Mahfouz, J. F. Dedieu, A. Brie, M. Perricaudet, and P. Yeh.
1999. RGD inclusion in the hexon monomer provides adenovirus type
5-based vectors with a fiber knob-independent pathway for infection. J. Vi-
rol. 73:5156–5161.
55. Wagner, E. K., and D. C. Bloom. 1997. Experimental investigation of herpes
simplex virus latency. Clin. Microbiol. Rev. 10:419–443.
56. Warner, M. S., R. J. Geraghty, W. M. Martinez, R. I. Montgomery, J. C.
Whitbeck, R. L. Xu, R. J. Eisenberg, G. H. Cohen, and P. G. Spear. 1998. A
cell surface protein with herpesvirus entry activity (Hveb) confers suscepti-
bility to infection by mutants of herpes simplex virus type 1, herpes simplex
virus type 2, and pseudorabies virus. Virology 246:179–189.
57. Weatherbee, J. A., R. B. Luftig, and R. R. Weihing. 1977. Binding of ade-
novirus to microtubules. II. Depletion of high-molecular-weight microtu-
bule-associated protein content reduces specificity of in vitro binding. J. Vi-
rol. 21:732–742.
VOL. 76, 2002 MTs ARE REQUIRED FOR Ad AND HSV-1 INFECTIONS 9971
